The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations.

Journal: Health and technology
Published Date:

Abstract

PURPOSE: This contribution explores the underuse of artificial intelligence (AI) in the health sector, what this means for practice, and how much the underuse can cost. Attention is drawn to the relevance of an issue that the European Parliament has outlined as a "major threat" in 2020. At its heart is the risk that research and development on trusted AI systems for medicine and digital health will pile up in lab centers without generating further practical relevance. Our analysis highlights why researchers, practitioners and especially policymakers, should pay attention to this phenomenon.

Authors

  • Ugo Pagallo
    Law School, University of Turin, Turin, Italy.
  • Shane O'Sullivan
    Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg im Breisgau, Germany.
  • Nathalie Nevejans
    Ethics and Procedures Center (CDEP), Faculty of Law of Douai, University of Artois, Arras, France.
  • Andreas Holzinger
    Human-Centered AI Lab, Medical University of Graz, Graz, Austria.
  • Michael Friebe
    Department of Measurements and Electronics, AGH University of Science and Technology, Krak'ow, Poland.
  • Fleur Jeanquartier
    Human-Centered AI Lab, Medical University of Graz, Graz, Austria.
  • Claire Jean-Quartier
    Human-Centered AI Lab, Medical University of Graz, Graz, Austria.
  • Arkadiusz Miernik
    Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg im Breisgau, Germany.

Keywords

No keywords available for this article.